JW Pharmaceutical Revenue

JW Pharmaceutical had revenue of 200.02B KRW in the quarter ending September 30, 2025, with 11.96% growth. This brings the company's revenue in the last twelve months to 764.21B, up 3.76% year-over-year. In the year 2024, JW Pharmaceutical had annual revenue of 719.38B, down -3.89%.

Revenue (ttm)

764.21B

Revenue Growth

+3.76%

P/S Ratio

1.01

Revenue / Employee

715.55M

Employees

1,068

Market Cap

773.12B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	719.38B	-29.15B	-3.89%
Dec 31, 2023	748.53B	64.18B	9.38%
Dec 31, 2022	684.35B	77.77B	12.82%
Dec 31, 2021	606.58B	59.25B	10.83%
Dec 31, 2020	547.34B	36.00B	7.04%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Daewoong	2.06T
Chong Kun Dang Pharmaceutical	1.68T
Dong-A Socio Holdings	1.40T
Boryung	1.03T
DongKook Pharmaceutical	894.93B
Huons Global	825.44B
Dong-A ST	770.63B
JW Pharmaceutical	764.21B

Revenue Rankings